Overview
Introduction
Mission Message
Collaborating Partners
RIGHT Team
Annual Reports
Council
Board of Directors
Selection Committee
Organization Chart
Investment
Investment Principles
Investment Priorities
Investment Area
Investment Process
Portfolio
Global Access Policy
News
Press Releases
News & Event
Publications
Notice
Careers
Contact
Contact
Apply for Funding
Type of Award
Product Development Award
RFP & Instructions
Intent to Apply
Technical Accelerator Award
RFP & Instructions
Full Proposal
RFP FAQ
EN
KO
✕
Featured News: Supply of hexavalent vaccines to developing countries could completely eradicate polio
Home
News & Event
Featured News: Supply of hexavalent vaccines to developing countries could completely eradicate polio
Featured News: Leveraging Korean’s technology in development of MGH-Harvard’s ‘Novel Cholera Conjugate Vaccine’
2020년 February 19일
Featured News: The key of new single-dose antimalarial drug is a Continuous Process Development
2020년 February 23일
2020년 February 21일
Categories
News & Event
Tags
Published in the The DOCTOR’S NEWS
This article is only available in Korean.
Original Article
Share
Related posts
2021년 February 18일
Column: Bora Kim, Program Associate of RIGHT Fund “Korea needs to grow interest in global public health market further”
Read more
2021년 January 22일
Interview: Myongsei Sohn, Chairman of the Board of Directors, RIGHT Fund “Support for Infectious Disease R&D Should Aim to Prepare for Future Disasters rather than an Immediate Result”
Read more
2021년 January 21일
Interview: Myongsei Sohn, Chairman of the Board of Directors, RIGHT Fund “No reasons to reject post that can enhance Korea’s healthcare status”
Read more
Contents in Preparation
×
